Skip to content

Application of palliative care in peri-chemoradiotherapy of malignant tumor patients

Application of palliative care in peri-chemoradiotherapy of malignant tumor patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033033
Enrollment
Unknown
Registered
2020-05-18
Start date
2020-05-17
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor

Interventions

Sponsors

The First Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. patients with pathologically or cytologically confirmed malignant tumors; 3. KPS score >=60 points; 4. the estimated survival time is at least 12 weeks; 5. heart, kidney and liver functions were basically normal, and there were no contraindications of chemotherapy and radiotherapy; 6. patients had good compliance and were followed up; 7. no mental disorder or confusion.

Exclusion criteria

Exclusion criteria: (1) patients who did not complete 2 cycles of radiotherapy or induction chemotherapy; (2) those who are illiterate or unable to understand relevant investigation contents; (3) persons without capacity for civil conduct, persons with limited capacity for civil conduct and patients with personality disorders or mental diseases; (4) do not agree to join the research.

Design outcomes

Primary

MeasureTime frame
symptoms;The quality of life;

Countries

China

Contacts

Public ContactLiu Fang

The First Medical Center of PLA General Hospital

liufangfsp@163.com+86 13520469875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026